Any vendor that does not provide a COA for each batch is not worth considering
In February 2026, about a year after the most recent GLP-1 shortage ended, the FDA issued a notice vowing to take action against mass-marketed compounded GLP-1s, including legal action and the seizure and injunction of non FDA-approved drugs
The Official Recommendation: 2 Months Before The FDA and prescribing information recommend stopping Ozempic at least 2 months (8 weeks) before a planned pregnancy
When glucose is present, ATP levels rise (cells use glucose to make more ATP)

KPV: Best for inflammatory pain and conditions Why KPV is superior for inflammation: Extremely potent anti-inflammatory peptide Reduces IL-6, TNF-alpha, other inflammatory markers Modulates immune response Works systemically Best for: Rheumatoid arthritis Autoimmune-related pain Inflammatory bowel disease with pain Chronic systemic inflammation Widespread pain from inflammation Dosing: Injectable: 500-1,000mcg daily subcutaneous Oral: 1-2mg daily for gut-specific inflammation 8-12 weeks minimum Can use long-term Expected results: Week 2-4: Reduced inflammatory markers Week 4-8: Decreased pain levels Week 8-12: Significant inflammation control Comparison to NSAIDs: KPV: Reduces inflammation without stomach damage NSAIDs: Temporary relief, stomach/kidney risks KPV safer long-term BPC-157 for inflammation + tissue healing Why BPC-157 for inflammatory pain: Anti-inflammatory effects Also heals tissue causing inflammation Dual benefit Best for: Inflammatory pain with tissue damage IBD/Crohn's (gut inflammation) General inflammatory conditions Can combine KPV + BPC-157: KPV: Powerful inflammation reduction BPC-157: Tissue healing Together = comprehensive inflammatory pain relief Best peptide for chronic widespread pain Fibromyalgia, chronic pain syndrome, multi-site pain
